XPOVIO: payments to doctors
Payments that named XPOVIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8M
- Providers
- 8,554
- Transactions
- 29,813
- Average per transaction
- $267
The per-transaction average — $267 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,554 providers the average total is $931, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Karyopharm Therapeutics Inc. | $7,960,337 | 100.0% |